§ Player · Midfielder

Jorthy Mokio

Ajax

In the 2025-26 Eredivisie, Jorthy Mokio has an NVP of 34: number 72 of 82 midfielders in the league with 900+ minutes.

They produce 0.97 times their position's average and cost 1.19 times as much.

Their strongest skill is Striker: B, percentile 68.

They have a rating in 19 matches that season and were player of the match in 0. Their best rating was 73, in Ajax 2–1 NAC Breda.

Seasons

SeasonCompetitionTeamMinGAProducesCostsNVP
2025-26 Eredivisie Ajax 146732 0.97× 1.19× 34
2024-25 Eredivisie Ajax 50410 0.82× 1.06× 30

Skills

Percentile against players in the same position in the 2025-26 Eredivisie, as on the app card.

StrikerB68
CreatorX22
DribblerX19
DefenderB68
ControlB65

Latest matches

  1. 41 Ajax 2–2 Excelsior19 Sep · Eredivisie · 76'
  2. 39 Ajax 5–1 Willem II15 Sep · Eredivisie · 90'
  3. 44 Fortuna Sittard 1–5 Ajax12 Sep · Eredivisie · 58'
  4. 57 Ajax 1–3 PSV5 Sep · Eredivisie · 73'
  5. 36 Telstar 0–4 Ajax30 Aug · Eredivisie · 90'
  6. 55 Ajax 5–3 Sion27 Aug · Conference League · 67'
  7. 60 Sion 2–4 Ajax20 Aug · Conference League · 44'
  8. 37 Shelbourne 2–2 Ajax13 Aug · Conference League · 90'
  9. 48 PEC Zwolle 0–2 Ajax9 Aug · Eredivisie · 29'
  10. 61 Ajax 3–1 Shelbourne6 Aug · Conference League · 32'

Best matches

  1. 73 Ajax 2–1 NAC Breda27 Sep 2025 · Eredivisie
  2. 72 Ajax 0–2 Benfica25 Nov 2025 · Champions League
  3. 71 Ajax 4–0 Heracles Almelo16 Feb 2025 · Eredivisie
  4. 65 Almere City 0–1 Ajax2 Mar 2025 · Eredivisie
  5. 65 Olympique Marseille 4–0 Ajax30 Sep 2025 · Champions League

How is the rating calculated?

The rating measures a single match: what the player produced against what they cost, compared with the average for their position in that league and season, and adjusted by position (a 70 for a forward is as hard to get as a 70 for a defender). A normal match is around 50, 70 is already very good and only one in a hundred goes above 80. It is not the NVP, which ranks the whole season.

See their card in La Lente All their metrics, recent form, comparisons and Same DNA.